Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.90%58.570.0%$919.92m
AMGNAmgen, Inc. 1.22%258.241.3%$759.50m
GILDGilead Sciences, Inc. 0.38%76.351.0%$735.36m
REGNRegeneron Pharmaceuticals, Inc. 2.18%622.452.5%$672.88m
NVAXNovavax, Inc. 2.43%81.64102.0%$616.96m
BIIBBiogen, Inc. 0.13%265.121.6%$544.40m
VRTXVertex Pharmaceuticals, Inc. 1.68%291.101.9%$526.40m
ILMNIllumina, Inc. 1.24%373.103.5%$309.63m
ALXNAlexion Pharmaceuticals, Inc. -0.08%112.302.0%$225.16m
BMRNBioMarin Pharmaceutical, Inc. 0.75%126.784.3%$216.16m
SGENSeattle Genetics, Inc. 0.90%169.036.1%$202.76m
SRNESorrento Therapeutics, Inc. -1.15%6.851.8%$187.20m
SRPTSarepta Therapeutics, Inc. -1.77%162.7513.9%$164.07m
INCYIncyte Corp. 3.72%106.472.5%$163.74m
IMMUImmunomedics, Inc. 1.71%37.5413.3%$157.98m

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.